Ocrelizumab Depletes CD20(+) T Cells in Multiple Sclerosis Patients

Gingele, S; Jacobus, TL; Konen, FF; Hummert, MW; Suhs, KW; Schwenkenbecher, P; Ahlbrecht, J; Mohn, N; Muschen, LH; Bonig, L; Alvermann, S; Schmidt, RE; Stangel, M; Jacobs, R; Skripuletz, T

Skripuletz, T (reprint author), Hannover Med Sch, Dept Neurol, D-30625 Hannover, Germany.

CELLS, 2019; 8 (1):

Abstract

Ocrelizumab, a humanized monoclonal anti-CD20 antibody, has shown pronounced effects in reduction of disease activity in multiple sclerosis (MS) patie......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索